Publications by authors named "Ben Haynes"

Claim this Profile
I
Impact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Ben P Haynes, Gene Schuster, Richard Buus, Anastasia Alataki, Ophira Ginsburg

Breast Cancer Res Treat· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
Richard Buus, Zsolt Szijgyarto, Eugene F Schuster, Hui Xiao, Ben P Haynes

NPJ Breast Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors.
Mariana Ferreira Leal, Ben P Haynes, Eugene Schuster, Belinda Yeo, Maria Afentakis

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer.
Ben P Haynes, Ophira Ginsburg, Qiong Gao, Elizabeth Folkerd, Maria Afentakis

NPJ Breast Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach.
Mariana Ferreira Leal, Ben P Haynes, Fiona A MacNeill, Andrew Dodson, Mitch Dowsett

Breast Cancer Res Treat· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterisation of aromatase inhibitor-resistant advanced breast cancer: the phenotypic effect of ESR1 mutations.
Elena Lopez-Knowles, Alex Pearson, Gene Schuster, Pascal Gellert, Ricardo Ribas, Ben Haynes

Br J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.
Ben P Haynes, Ophira Ginsburg, Qiong Gao, Elizabeth Folkerd, Maria Afentakis

NPJ Breast Cancer· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to: Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.
Ben P Haynes, Giuseppe Viale, Viviana Galimberti, Nicole Rotmensz, Bianca Gibelli

Breast Cancer Res Treat· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancer.
Ben P Haynes, Giuseppe Viale, Viviana Galimberti, Nicole Rotmensz, Bianca Gibelli

Breast Cancer Res Treat· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inverse regulation of EGFR/HER1 and HER2-4 in normal and malignant human breast tissue.
Marianne Hauglid Flågeng, Stian Knappskog, Ben P Haynes, Per Eystein Lønning, Gunnar Mellgren

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study.
Nichola Johnson, Frank Dudbridge, Nick Orr, Lorna Gibson, Michael E Jones, Ben P Haynes

Breast Cancer Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancer.
Ben P Haynes, Giuseppe Viale, Viviana Galimberti, Nicole Rotmensz, Bianca Gibelli

Breast Cancer Res Treat· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP3A variation, premenopausal estrone levels, and breast cancer risk.
Nichola Johnson, Kate Walker, Lorna J Gibson, Nick Orr, Elizabeth Folkerd, Ben Haynes

J Natl Cancer Inst· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients.
James M Rae, Suzy Drury, Daniel F Hayes, Vered Stearns, Jacklyn N Thibert, Ben P Haynes

J Natl Cancer Inst· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring breast cancer estrogen disposition: the basis for endocrine manipulation.
Per E Lønning, Ben P Haynes, Anne H Straume, Anita Dunbier, Hildegunn Helle

Clin Cancer Res· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent data on intratumor estrogens in breast cancer.
Per E Lønning, Ben P Haynes, Anne H Straume, Anita Dunbier, Hildegunn Helle

Steroids· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intratumoral estrogen disposition in breast cancer.
Ben P Haynes, Anne Hege Straume, Jürgen Geisler, Roger A'Hern, Hildegunn Helle

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
Jürgen Geisler, Ben Haynes, Dagfinn Ekse, Mitch Dowsett, Per Eystein Lønning

J Steroid Biochem Mol Biol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.
Sanober A Amin, Chiang-Ching Huang, Scott Reierstad, Zhihong Lin, Zarema Arbieva, Ben Haynes

Mol Cell Endocrinol· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biology of steroid hormones and endocrine treatment of breast cancer.
Mitch Dowsett, Elizabeth Folkerd, Deborah Doody, Ben Haynes

Breast· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
Jürgen Geisler, Ben Haynes, Gun Anker, Hildegunn Helle, Dagfinn Ekse

J Steroid Biochem Mol Biol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study.
Jürgen Geisler, Ben Haynes, Gun Anker, Mitch Dowsett, Per Eystein Lønning

J Clin Oncol· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis